BNGO RSI Chart
Last 7 days
17.7%
Last 30 days
37.8%
Last 90 days
-9.6%
Trailing 12 Months
-83.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 37.5M | 0 | 0 | 0 |
2023 | 29.5M | 31.5M | 33.6M | 36.1M |
2022 | 20.5M | 23.3M | 25.9M | 27.8M |
2021 | 10.5M | 13.2M | 15.7M | 18.0M |
2020 | 9.4M | 8.4M | 7.3M | 8.5M |
2019 | 12.1M | 10.9M | 11.4M | 10.1M |
2018 | 9.6M | 10.7M | 10.8M | 12.0M |
2017 | 0 | 0 | 0 | 9.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 15, 2024 | dixon jonathan v. | sold (taxes) | -510 | 1.27 | -402 | general counsel |
Feb 15, 2024 | chaubey alka | sold (taxes) | -1,372 | 1.27 | -1,081 | chief medical officer |
Feb 15, 2024 | oldakowski mark | sold (taxes) | -1,560 | 1.27 | -1,229 | chief operating officer |
Feb 15, 2024 | holmlin r. erik | sold (taxes) | -3,902 | 1.27 | -3,073 | president and ceo |
Sep 18, 2023 | chaubey alka | acquired | - | - | 20,000 | chief medical officer |
Sep 18, 2023 | oldakowski mark | acquired | - | - | 20,000 | chief operating officer |
Jun 13, 2023 | mamuszka hannah | bought | 49,999 | 0.76 | 65,789 | - |
May 16, 2023 | holmlin r. erik | bought | 9,639 | 0.6426 | 15,000 | president and ceo |
May 12, 2023 | oldakowski mark | sold (taxes) | -27,387 | 0.66 | -41,496 | chief operating officer |
May 12, 2023 | holmlin r. erik | sold (taxes) | -33,093 | 0.66 | -50,141 | president and ceo |
Which funds bought or sold BNGO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | added | 129 | 45,447 | 175,184 | -% |
May 15, 2024 | D. E. Shaw & Co., Inc. | sold off | -100 | -324,621 | - | -% |
May 15, 2024 | CITADEL ADVISORS LLC | added | 18.79 | -115,553 | 266,639 | -% |
May 15, 2024 | Royal Bank of Canada | unchanged | - | - | - | -% |
May 15, 2024 | CANTOR FITZGERALD, L. P. | sold off | -100 | -750,300 | - | -% |
May 15, 2024 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | added | 385 | 94.00 | 145 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | sold off | -100 | -770,003 | - | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | sold off | -100 | -371,260 | - | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | reduced | -27.85 | -53,822 | 39,578 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -80.65 | -15,393 | 1,973 | -% |
Unveiling BioNano Genomics Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to BioNano Genomics Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
BioNano Genomics Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -18.2% | 8,769,000 | 10,721,000 | 9,318,000 | 8,662,000 | 7,415,000 | 8,215,000 | 7,221,000 | 6,670,000 | 5,696,000 | 6,302,000 | 4,655,000 | 3,856,000 | 3,168,000 | 3,989,500 | 2,196,000 | 1,182,000 | 1,136,000 | 2,789,130 | 3,313,000 | 2,175,000 | 1,853,000 |
Costs and Expenses | 23.9% | 33,947,000 | 27,391,000 | 115,961,000 | 41,546,000 | 39,913,000 | 39,331,500 | 33,958,000 | 33,550,000 | 30,804,000 | 29,022,000 | 21,832,000 | 17,915,000 | 12,206,000 | 12,305,000 | 10,963,000 | 8,014,000 | 10,042,000 | 8,258,864 | 6,623,000 | 7,464,000 | 6,891,000 |
S&GA Expenses | 24.5% | 19,536,000 | 15,690,500 | 24,896,000 | 26,936,000 | 25,976,000 | 25,320,500 | 21,216,000 | 21,783,000 | 20,277,000 | 19,806,500 | 15,327,000 | 13,829,000 | 9,528,000 | 9,428,000 | 8,659,000 | 5,613,000 | 7,368,000 | 5,859,876 | 4,449,000 | 5,056,000 | 4,791,000 |
R&D Expenses | -16.4% | 9,779,000 | 11,700,500 | 13,785,000 | 14,610,000 | 13,937,000 | 14,011,000 | 12,742,000 | 11,767,000 | 10,527,000 | 9,215,500 | 6,505,000 | 4,086,000 | 2,678,000 | 2,877,000 | 2,304,000 | 2,401,000 | 2,674,000 | 2,398,891 | 2,174,000 | 2,408,000 | 2,100,000 |
EBITDA Margin | 8.6% | -5.41 | -5.91 | -6.31 | -4.21 | -4.30 | -4.34 | -4.39 | -4.48 | -4.52 | -4.11 | -3.65 | -3.55 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 14.7% | 5,620,000 | 4,898,000 | 71,000 | 74,000 | 76,000 | 74,500 | 73,000 | 74,000 | 77,000 | 42,000 | 2,000 | 268,000 | 600,000 | 1,068,000 | 589,000 | 561,000 | 761,000 | 731,696 | 578,000 | 645,000 | 273,000 |
Income Taxes | 50.0% | -18,000 | -36,000 | 39,000 | 33,000 | 26,000 | 1,805,500 | 28,000 | 41,000 | 9,000 | -5,767,000 | 35,000 | 9,000 | 6,000 | -11,000 | 30,000 | 5,000 | 5,000 | 7,548 | 4,000 | 5,000 | 5,000 |
Earnings Before Taxes | 28.4% | -31,440,000 | -43,927,000 | -112,527,000 | -38,879,000 | -37,098,000 | -36,871,500 | -31,781,000 | -32,117,000 | -29,943,000 | -28,716,000 | -20,718,000 | -18,777,000 | -9,941,000 | -11,741,000 | -10,762,000 | -8,069,000 | -10,505,000 | -7,893,022 | -6,394,000 | -7,660,000 | -7,847,000 |
EBT Margin | 6.0% | -6.05 | -6.44 | -6.71 | -4.59 | -4.67 | -4.70 | -4.73 | -4.78 | -4.79 | -4.35 | -3.90 | -3.88 | - | - | - | - | - | - | - | - | - |
Net Income | 28.4% | -31,422,000 | -43,891,000 | -112,566,000 | -38,912,000 | -37,124,000 | -38,677,000 | -31,809,000 | -32,158,000 | -29,952,000 | -22,949,000 | -20,753,000 | -18,786,000 | -9,947,000 | -11,730,000 | -10,792,000 | -8,074,000 | -10,510,000 | -7,900,000 | -6,398,000 | -7,665,000 | -7,852,000 |
Net Income Margin | 6.0% | -6.05 | -6.44 | -6.76 | -4.65 | -4.73 | -4.77 | -4.51 | -4.54 | -4.51 | -4.03 | -3.91 | -3.88 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 5.5% | -28,131,000 | -29,779,000 | -26,561,000 | -36,977,000 | -32,668,000 | -34,785,000 | -29,741,000 | -28,600,000 | -32,762,000 | -25,890,000 | -20,250,000 | -12,471,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -26.3% | 158 | 214 | 182 | 271 | 292 | 308 | 324 | 322 | 348 | 377 | 360 | 357 | 385 | 60.00 | 41.00 | 27.00 | 19.00 | 30.00 | 19.00 | 25.00 | 30.00 |
Current Assets | -38.9% | 86.00 | 140 | 105 | 123 | 143 | 157 | 218 | 216 | 242 | 272 | 342 | 342 | 370 | 47.00 | 29.00 | 25.00 | 17.00 | 28.00 | 18.00 | 24.00 | 28.00 |
Cash Equivalents | -10.0% | 16.00 | 18.00 | 35.00 | 15.00 | 4.00 | 5.00 | 28.00 | 27.00 | 24.00 | 25.00 | 141 | 333 | 362 | 38.00 | 19.00 | 17.00 | 8.00 | 17.00 | 8.00 | 15.00 | 21.00 |
Inventory | -13.8% | 24.00 | 28.00 | - | 32.00 | 33.00 | 30.00 | 25.00 | 21.00 | 16.00 | 12.00 | 9.00 | 5.00 | 3.00 | 3.00 | 5.00 | 3.00 | 4.00 | 3.00 | 3.00 | 3.00 | 1.00 |
Net PPE | 8.3% | 25.00 | 23.00 | 21.00 | 20.00 | 19.00 | 18.00 | 16.00 | 14.00 | 13.00 | 10.00 | 9.00 | 6.00 | 6.00 | 5.00 | 4.00 | 3.00 | 2.00 | 2.00 | 1.00 | 1.00 | 2.00 |
Goodwill | - | - | - | - | 77.00 | 77.00 | 77.00 | 56.00 | 56.00 | 56.00 | 56.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | - | - | - | - | - | - |
Liabilities | -36.4% | 75.00 | 118 | 63.00 | 57.00 | 61.00 | 58.00 | 42.00 | 37.00 | 37.00 | 40.00 | 18.00 | 11.00 | 22.00 | 25.00 | 27.00 | 21.00 | 23.00 | 27.00 | 27.00 | 27.00 | 24.00 |
Current Liabilities | -41.5% | 59.00 | 100 | 40.00 | 33.00 | 38.00 | 36.00 | 34.00 | 28.00 | 19.00 | 22.00 | 18.00 | 11.00 | 7.00 | 9.00 | 25.00 | 20.00 | 23.00 | 26.00 | 7.00 | 8.00 | 5.00 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.00 | 16.00 | 2.00 | 2.00 | - | - | 19.00 | 19.00 | 18.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.00 | 14.00 | 17.00 | 20.00 | - | - | - |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.00 | 16.00 | 2.00 | 2.00 | - | - | 19.00 | 19.00 | 18.00 |
Shareholder's Equity | -13.9% | 83.00 | 96.00 | 119 | 215 | 231 | 249 | 282 | 285 | 311 | 337 | 342 | 346 | 363 | 35.00 | 15.00 | 6.00 | - | 4.00 | - | - | 6.00 |
Retained Earnings | -5.4% | -612 | -581 | -537 | -424 | -385 | -348 | -310 | -278 | -246 | -216 | -193 | -172 | -153 | -143 | -132 | -121 | -113 | -102 | -94.68 | -88.28 | -80.61 |
Additional Paid-In Capital | 2.7% | 695 | 677 | 656 | 640 | 618 | 599 | 594 | 565 | 559 | 554 | 535 | 518 | 516 | 179 | 147 | 127 | 109 | 106 | 87.00 | 87.00 | 86.00 |
Shares Outstanding | 25.8% | 58.00 | 46.00 | 35.00 | 33.00 | 31.00 | 30.00 | 29.00 | 29.00 | 28.00 | 29.00 | 28.00 | 28.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 201 | - | - | - | 400 | - | - | - | 2,045 | - | - | - | 27.00 | - | - | - | 27.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 5.5% | -28,131 | -29,779 | -26,293 | -36,709 | -32,400 | -34,517 | -29,473 | -28,332 | -32,494 | -25,622 | -19,982 | -12,419 | -13,904 | -12,104 | -10,960 | -7,218 | -8,032 | -9,352 | -7,280 | -6,316 | -6,552 |
Share Based Compensation | -10.6% | 3,015 | 3,372 | 3,992 | 3,932 | 3,882 | 5,479 | 6,059 | 5,777 | 5,102 | 4,802 | 2,788 | 1,758 | 371 | 451 | 447 | 328 | 328 | 356 | 365 | 336 | 289 |
Cashflow From Investing | 185.9% | 47,586 | -55,373 | 33,427 | 29,576 | 16,528 | 11,610 | 7,953 | 31,240 | 31,964 | -92,510 | -185,602 | 74.00 | -24.00 | - | -2,450 | - | - | -23.06 | -8.00 | -30.00 | - |
Cashflow From Financing | -131.6% | -21,618 | 68,484 | 12,588 | 17,881 | 14,862 | 146 | 22,651 | 203 | 7.00 | 1,967 | 13,766 | -17,158 | 337,536 | 31,686 | 15,083 | 16,268 | -1,135 | 18,491 | 218 | 811 | 10,859 |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue: | ||
Total revenue | $ 8,769 | $ 7,415 |
Cost of revenue: | ||
Total cost of revenue | 5,945 | 5,345 |
Operating expenses: | ||
Research and development | 9,779 | 13,937 |
Selling, general and administrative | 19,536 | 25,976 |
Restructuring costs | 4,632 | 0 |
Total operating expenses | 33,947 | 39,913 |
Loss from operations | (31,123) | (37,843) |
Other income (expense): | ||
Interest income | 1,044 | 704 |
Interest expense | (122) | (76) |
Other income (expense) | (1,239) | 117 |
Total other income (expense) | (317) | 745 |
Loss before income taxes | (31,440) | (37,098) |
Benefit (provision) for income taxes | 18 | (26) |
Net loss | $ (31,422) | $ (37,124) |
Net loss per share, basic (in dollars per share) | $ (0.60) | $ (1.23) |
Net loss per share, diluted (in dollars per share) | $ (0.60) | $ (1.23) |
Weighted-average common shares outstanding, basic (in shares) | 52,739 | 30,205 |
Weighted-average common shares outstanding, diluted (in shares) | 52,739 | 30,205 |
Product revenue | ||
Revenue: | ||
Total revenue | $ 6,828 | $ 5,447 |
Cost of revenue: | ||
Total cost of revenue | 4,904 | 3,858 |
Service and other revenue | ||
Revenue: | ||
Total revenue | 1,941 | 1,968 |
Cost of revenue: | ||
Total cost of revenue | $ 1,041 | $ 1,487 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 15,759 | $ 17,948 |
Investments | 12,561 | 48,823 |
Accounts receivable, net | 8,313 | 9,319 |
Inventory | 19,587 | 22,892 |
Prepaid expenses and other current assets | 4,945 | 6,019 |
Restricted investments | 24,446 | 35,117 |
Total current assets | 85,611 | 140,118 |
Restricted cash | 400 | 400 |
Property and equipment, net | 25,279 | 23,345 |
Operating lease right-of-use assets | 4,870 | 5,633 |
Finance lease right-of-use assets | 3,453 | 3,503 |
Intangible assets, net | 31,734 | 33,974 |
Other long-term assets | 6,648 | 7,431 |
Total assets | 157,995 | 214,404 |
Current liabilities: | ||
Accounts payable | 9,844 | 10,384 |
Accrued expenses | 11,028 | 8,089 |
Contract liabilities | 1,035 | 783 |
Operating lease liability | 2,190 | 2,163 |
Finance lease liability | 269 | 272 |
Purchase option liability (at fair value) | 5,060 | 8,534 |
Convertible notes payable (at fair value) | 29,080 | 69,803 |
Total current liabilities | 58,506 | 100,028 |
Operating lease liability, net of current portion | 2,755 | 3,590 |
Finance lease liability, net of current portion | 3,575 | 3,585 |
Contingent consideration | 10,250 | 10,890 |
Long-term contract liabilities | 138 | 154 |
Total liabilities | 75,224 | 118,247 |
Commitments and contingencies (Note 7) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value; 10,000,000 shares authorized at March 31, 2024 and December 31, 2023; no shares issued and outstanding at March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $0.0001 par value, 400,000,000 shares authorized at March 31, 2024 and December 31, 2023; 57,539,000 and 45,752,000 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 6 | 5 |
Additional paid-in capital | 695,411 | 677,337 |
Accumulated deficit | (612,630) | (581,208) |
Accumulated other comprehensive income (loss) | (16) | 23 |
Total stockholders’ equity | 82,771 | 96,157 |
Total liabilities and stockholders’ equity | $ 157,995 | $ 214,404 |